News Releases

Anixa Biosciences Enters Letter of Intent with VERDI Solutions to Develop Artificial Intelligence-Guided Personalized and Off-the-Shelf Cancer Vaccines

March 25, 2025

Anixa Biosciences Receives Notice of Allowance from USPTO for Ovarian Cancer Vaccine

March 24, 2025

Anixa Biosciences CEO to Present at the 2025 CAGLA NeauxCancer Conference on March 28th

March 17, 2025

Anixa Biosciences 2025 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested Parties

March 10, 2025

Anixa Biosciences Announces Chief Development Officer Dr. Pam Garzone to Speak at the Alliance for Cancer Gene Therapy Summit 2025 on March 19th

March 3, 2025

Anixa Biosciences and Moffitt Cancer Center Complete Dosing in Third Cohort in Ovarian Cancer CAR-T Clinical Trial

February 26, 2025

Anixa Biosciences' Breast Cancer Vaccine was Featured on Fox News' "America Reports"

February 25, 2025

Anixa Biosciences Featured in Breaking Cancer News Article on Novel CAR-T Therapy for Ovarian Cancer

February 24, 2025

Anixa Biosciences Announces Approval of Protocol Amendment for Ovarian Cancer CAR-T Clinical Trial

February 18, 2025

Anixa Biosciences Chairman and CEO Discusses Pioneering CAR-T Cell Therapy and Breast Cancer Vaccine in Alpha Wolf Trading Interview

February 14, 2025

1
2
3
4
5
6
7
8
9
10
...27
Next »

Latest News & Events

Mar 25, 2025

Anixa Biosciences Enters Letter of Intent with VERDI Solutions to Develop Artificial Intelligence-Guided Personalized and Off-the-Shelf Cancer Vaccines

Read More...

Mar 24, 2025

Anixa Biosciences Receives Notice of Allowance from USPTO for Ovarian Cancer Vaccine

Read More...

Mar 17, 2025

Anixa Biosciences CEO to Present at the 2025 CAGLA NeauxCancer Conference on March 28th

Read More...